USD 1.23
(-0.81%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -15.25 Million USD | 7.51% |
2022 | -16.49 Million USD | -71.83% |
2021 | -9.59 Million USD | -121.26% |
2020 | -4.07 Million ILS | 6.36% |
2019 | -4.59 Million ILS | -35.36% |
2018 | -3.42 Million ILS | -24.42% |
2017 | -2.75 Million ILS | 9.35% |
2016 | -3.03 Million ILS | 11.63% |
2015 | -3.68 Million ILS | 14.0% |
2014 | -3.98 Million ILS | -1.1% |
2013 | -3.94 Million ILS | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -3.53 Million USD | -6.99% |
2024 Q2 | -3.1 Million USD | 11.75% |
2023 Q3 | -4.04 Million USD | -0.97% |
2023 FY | - USD | 7.51% |
2023 Q1 | -3.87 Million USD | -0.52% |
2023 Q2 | -4 Million USD | -3.2% |
2023 Q4 | -3.5 Million USD | 13.2% |
2022 Q2 | -4.22 Million USD | 3.29% |
2022 FY | - USD | -71.83% |
2022 Q4 | -3.85 Million USD | 4.29% |
2022 Q1 | -4.37 Million USD | -41.66% |
2022 Q3 | -4.03 Million USD | 4.68% |
2021 Q4 | -3.08 Million USD | -9.7% |
2021 Q2 | -2.52 Million USD | -115.9% |
2021 Q1 | -1.17 Million USD | -0.86% |
2021 FY | - USD | -121.26% |
2021 Q3 | -2.81 Million USD | -11.4% |
2020 FY | - ILS | 6.36% |
2020 Q4 | -1.16 Million USD | 12.52% |
2020 Q2 | -796.5 Thousand USD | 0.0% |
2020 Q1 | -796.5 Thousand USD | 26.28% |
2020 Q3 | -1.32 Million USD | -66.48% |
2019 Q3 | -1.07 Million USD | 6.62% |
2019 Q4 | -1.08 Million USD | -0.66% |
2019 FY | - ILS | -35.36% |
2019 Q2 | -1.14 Million USD | -1.79% |
2019 Q1 | -1.12 Million USD | -24.86% |
2018 Q1 | -795.62 Thousand USD | -24.26% |
2018 FY | - ILS | -24.42% |
2018 Q4 | -904.37 Thousand USD | -12.87% |
2018 Q3 | -801.25 Thousand USD | -5.52% |
2018 Q2 | -759.36 Thousand USD | 4.56% |
2017 Q3 | -683.11 Thousand USD | -6.4% |
2017 FY | - ILS | 9.35% |
2017 Q4 | -640.3 Thousand USD | 6.27% |
2017 Q1 | -618.32 Thousand USD | 11.86% |
2017 Q2 | -642 Thousand USD | -3.83% |
2016 Q4 | -701.54 Thousand USD | -32.67% |
2016 Q1 | -1.08 Million USD | -65.55% |
2016 Q2 | -767.57 Thousand USD | 29.45% |
2016 Q3 | -528.77 Thousand USD | 31.11% |
2016 FY | - ILS | 11.63% |
2015 Q3 | -923.33 Thousand USD | -1.88% |
2015 Q4 | -657.14 Thousand USD | 28.83% |
2015 Q2 | -906.31 Thousand USD | 8.29% |
2015 Q1 | -988.25 Thousand USD | -16.16% |
2015 FY | - ILS | 14.0% |
2014 Q3 | -1.11 Million USD | 4.58% |
2014 FY | - ILS | -1.1% |
2014 Q1 | -1.17 Million USD | -16.02% |
2014 Q2 | -1.16 Million USD | 0.87% |
2014 Q4 | -850.8 Thousand USD | 23.47% |
2013 Q4 | -1.01 Million USD | -36.57% |
2013 Q1 | -914.62 Thousand USD | 17.89% |
2013 FY | - ILS | 0.0% |
2013 Q2 | -858.37 Thousand USD | 6.15% |
2013 Q3 | -741.81 Thousand USD | 13.58% |
2012 Q4 | -1.11 Million USD | 1.97% |
2012 Q3 | -1.13 Million USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Acutus Medical, Inc. | -13.48 Million USD | -13.094% |
Cerus Corporation | -26.53 Million USD | 42.52% |
OrthoPediatrics Corp. | -8.38 Million USD | -81.995% |
PetVivo Holdings, Inc. | -10.49 Million USD | -45.343% |
Talis Biomedical Corporation | -66.04 Million USD | 76.905% |
Vivos Therapeutics, Inc. | -16.67 Million USD | 8.528% |
Inogen, Inc. | -45.67 Million USD | 66.608% |
Spectral AI, Inc. | -12.26 Million USD | -24.392% |
Nano-X Imaging Ltd. | -47.69 Million USD | 68.018% |
CVRx, Inc. | -38.73 Million USD | 60.618% |
DIH Holding US, Inc. Warrants | -3.52 Million USD | -332.341% |
Helius Medical Technologies, Inc. | -12.1 Million USD | -25.985% |
Orthofix Medical Inc. | -86.98 Million USD | 82.465% |
Venus Concept Inc. | -26.11 Million USD | 41.588% |
Accelerate Diagnostics, Inc. | -49.77 Million USD | 69.354% |
Bioventus Inc. | -23.07 Million USD | 33.884% |
BrainsWay Ltd. | -2.31 Million USD | -560.017% |
Envoy Medical, Inc. | -18.23 Million USD | 16.367% |
electroCore, Inc. | -17.76 Million USD | 14.116% |
Lucid Diagnostics Inc. | -49.75 Million USD | 69.341% |
Monogram Orthopaedics, Inc. | -16.85 Million USD | 9.508% |
MaxCyte, Inc. | -44.12 Million USD | 65.435% |
NeuroOne Medical Technologies Corporation | -11.75 Million USD | -29.747% |
Nexalin Technology, Inc. | -5.69 Million USD | -167.971% |
PAVmed Inc | -75.74 Million USD | 79.862% |
Rapid Micro Biosystems, Inc. | -53.75 Million USD | 71.627% |
RxSight, Inc. | -41.03 Million USD | 62.831% |
Sight Sciences, Inc. | -49.41 Million USD | 69.133% |
SI-BONE, Inc. | -34.44 Million USD | 55.719% |
TELA Bio, Inc. | -40.63 Million USD | 62.462% |
TriSalus Life Sciences, Inc. | -58.29 Million USD | 73.836% |
Treace Medical Concepts, Inc. | -39 Million USD | 60.898% |
LivaNova PLC | 39.01 Million USD | 139.094% |
908 Devices Inc. | -34.02 Million USD | 55.171% |
Alphatec Holdings, Inc. | -110.59 Million USD | 86.208% |
Nemaura Medical Inc. | -7.28 Million USD | -109.316% |
NeuroPace, Inc. | -22.83 Million USD | 33.2% |
LENSAR, Inc. | -8.71 Million USD | -75.04% |
Apyx Medical Corporation | -18.11 Million USD | 15.785% |
Cutera, Inc. | -136.56 Million USD | 88.831% |
STRATA Skin Sciences, Inc. | -3.38 Million USD | -351.272% |
BioSig Technologies, Inc. | -28.15 Million USD | 45.817% |
Anika Therapeutics, Inc. | 2.51 Million USD | 706.24% |
ClearPoint Neuro, Inc. | -20.98 Million USD | 27.329% |
Integra LifeSciences Holdings Corporation | 383.56 Million USD | 103.977% |
Axonics, Inc. | 7.77 Million USD | 296.18% |
Outset Medical, Inc. | -153.78 Million USD | 90.082% |
IRIDEX Corporation | -7.44 Million USD | -104.793% |
PROCEPT BioRobotics Corporation | -98.09 Million USD | 84.451% |
IRadimed Corporation | 20.8 Million USD | 173.329% |
Tivic Health Systems, Inc. | -8.06 Million USD | -89.196% |
INVO Bioscience, Inc. | -6.88 Million USD | -121.7% |
Telesis Bio, Inc. | -40.49 Million USD | 62.332% |
Viemed Healthcare, Inc. | 36.67 Million USD | 141.587% |
Varex Imaging Corporation | 67.2 Million USD | 122.698% |
Quipt Home Medical Corp. | 44.07 Million USD | 134.61% |
Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -40.322% |
Pulmonx Corporation | -55.09 Million USD | 72.314% |
Dynatronics Corporation | -976 Thousand USD | -1462.795% |
Modular Medical, Inc. | -17.1 Million USD | 10.817% |
ReShape Lifesciences Inc. | -14.48 Million USD | -5.302% |
Semler Scientific, Inc. | 23.58 Million USD | 164.661% |
InMode Ltd. | 196.28 Million USD | 107.771% |
Bruker Corporation | 599 Million USD | 102.546% |
Cytosorbents Corporation | -28.81 Million USD | 47.058% |
DexCom, Inc. | 916.7 Million USD | 101.664% |
Align Technology, Inc. | 799.03 Million USD | 101.909% |
Viveve Medical, Inc. | -20.61 Million USD | 26.017% |
ZimVie Inc. | 91.07 Million USD | 116.748% |
Movano Inc. | -29.12 Million USD | 47.629% |
Cytek Biosciences, Inc. | -4.4 Million USD | -246.03% |
Nexalin Technology, Inc. | -5.69 Million USD | -167.971% |
DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -332.341% |
Tandem Diabetes Care, Inc. | -194.65 Million USD | 92.164% |
Profound Medical Corp. | -27.12 Million USD | 43.765% |
Insulet Corporation | 323.6 Million USD | 104.714% |
enVVeno Medical Corporation | -25.01 Million USD | 39.032% |
Surmodics, Inc. | 1.18 Million USD | 1383.923% |
iCAD, Inc. | -6.56 Million USD | -132.338% |
Nuwellis, Inc. | -16.35 Million USD | 6.744% |
Biotricity, Inc. | -8.82 Million USD | -72.775% |
iRhythm Technologies, Inc. | -96.86 Million USD | 84.253% |
Aethlon Medical, Inc. | -11.84 Million USD | -28.727% |
InspireMD, Inc. | -20.91 Million USD | 27.058% |
PAVmed Inc. | -75.74 Million USD | 79.862% |
BIOLASE, Inc. | -15.13 Million USD | -0.753% |
Beyond Air, Inc. | -59.03 Million USD | 74.161% |
FONAR Corporation | 28.25 Million USD | 153.99% |
AxoGen, Inc. | -13.32 Million USD | -14.443% |
Vivani Medical, Inc. | -26.6 Million USD | 42.675% |
Tactile Systems Technology, Inc. | 24.54 Million USD | 162.153% |
Inari Medical, Inc. | 7.11 Million USD | 314.438% |
UFP Technologies, Inc. | 72.74 Million USD | 120.968% |
QT Imaging Holdings, Inc. | -3.38 Million USD | -350.501% |
Heart Test Laboratories, Inc. | -6.15 Million USD | -147.775% |
Tenon Medical, Inc. | -15.52 Million USD | 1.771% |
Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 0.085% |
Co-Diagnostics, Inc. | -41.47 Million USD | 63.224% |
AdaptHealth Corp. | -171.09 Million USD | 91.085% |
Sintx Technologies, Inc. | -6.6 Million USD | -131.106% |
NanoVibronix, Inc. | -3.43 Million USD | -344.047% |
Quanterix Corporation | -38.08 Million USD | 59.953% |
Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -40.322% |
Sensus Healthcare, Inc. | 30 Thousand USD | 50943.333% |
Pacific Biosciences of California, Inc. | -277.28 Million USD | 94.499% |
TransMedics Group, Inc. | -7.6 Million USD | -100.618% |
ReWalk Robotics Ltd. | -21.76 Million USD | 29.92% |
NeuroMetrix, Inc. | -7.09 Million USD | -114.958% |
Hyperfine, Inc. | -47.06 Million USD | 67.589% |
Establishment Labs Holdings Inc. | -58.3 Million USD | 73.84% |
Biomerica, Inc. | -5.99 Million USD | -154.514% |
Bone Biologics Corporation | 479.57 Thousand USD | 3280.544% |
AVITA Medical, Inc. | -39.56 Million USD | 61.451% |
Bluejay Diagnostics, Inc. | -9.17 Million USD | -66.283% |
Silk Road Medical, Inc | -45.08 Million USD | 66.165% |